Decheng Capital Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$661.3M
Q ending 2026-03-31
Prior quarter
$743.4M
Q ending 2025-12-31
Change
-11.0% QoQ · +85.5% YoY
Positions
14
reported holdings
Largest positions
All 14 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Cg Oncology Inc | CGON | Shares | $431.2M | 6.4M |
| Nuvation Bio Inc. | NUVB | Shares | $111.3M | 26.0M |
| Upstream Bio Inc. | UPB | Shares | $24.5M | 2.7M |
| Aclaris Therapeutics, Inc. | ACRS | Shares | $15.2M | 4.0M |
| Aardvark Therapeutics Inc | AARD | Shares | $14.8M | 3.9M |
| Lyell Immunopharma, Inc. | Shares | $13.9M | 692K | |
| Newamsterdam Pharma Co Nv | Shares | $10.4M | 325K | |
| Arcus Biosciences, Inc | RCUS | Shares | $10.3M | 478K |
| Revolution Medicines Inc(Nsm) | RVMD | Shares | $9.1M | 94K |
| Equillium Inc. | EQ | Shares | $8.9M | 4.4M |
| Beyondspring Inc. | Shares | $6.2M | 3.8M | |
| Zentalis Pharmaceuticals Inc. | ZNTL | Shares | $3.1M | 1.3M |
| Krystal Biotech Inc | KRYS | Shares | $1.9M | 7K |
| Pyxis Oncology, Inc (Formerly Apex | PYXS | Shares | $477K | 327K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.